Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Neck pain is in fourth place among the pathologies that result in the state of disability. Acute neck pain improves greatly within 2 months, while neck pain that persists for more than 3 months takes the form of chronic neck pain. Pain adversely affects people's activities of daily living. Treatment applications such as electrotherapy, hot and cold applications are applied for purposes such as reducing pain and muscle spasm and correcting functions. In addition to such treatment options, instrument-assisted soft tissue mobilization (IASTM) and foam roller therapy have been started to be applied in many disease groups in recent years and have attracted great attention. iASTM and Foam Roller is a technique that involves the use of tools in disorders of musculoskeletal pathology and to help heal soft tissues.
The aim of this study is to investigate the effects of foam roller technique with instrument-assisted soft tissue mobilization technique in individuals of different ages with chronic non-specific neck pain. According to the data obtained, the techniques the investigators will use, together with physiotherapy programs, contribute to the treatment of individuals with chronic non-specific neck pain and to the literature.is expected to provide.
In the study, Foam Roller will be applied to individuals with chronic non-specific neck pain with iASTM and the effect of these techniques will be examined. Demographic information of individuals will be recorded; individuals will be evaluated in detail in terms of muscle strength, flexibility, pain and secondary outcome measures. Individuals in terms of secondary outcome measures; functional status,joint range of motion and quality of life will be evaluated.
The work plan; pre-treatment evaluation, followed by treatment, second evaluation immediately after the end of treatment and control evaluation (third evaluation) 1 month after the end of treatment. The data collection period is planned as 1 year.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control Group | Other | An average of 20 people will be taken into the control group. |
|
| IASTM Treatment Group | Experimental | An average of 20 people will receive IASTM application treatment. |
|
| Foam Roller Treatment Group | Experimental | An average of 20 people will receive Foam Roller application treatment. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Classical Physiotherapy | Other | Only classical physiotherapy application, 5 sessions per week for 4 weeks. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Muscle Strength Assessment | A digital muscle dynamometer will be used to evaluate the muscle strength of the patients. | Pre-treatment assessment. |
| Muscle Strength Assessment | A digital muscle dynamometer will be used to evaluate the muscle strength of the patients. | Second evaluation immediately after the end of 4 weeks of treatment. |
| Muscle Strength Assessment | A digital muscle dynamometer will be used to evaluate the muscle strength of the patients. | Control evaluation 1 month after the end of treatment (third evaluation). |
| Flexibility Assessment | A tape measure will be used to assess patients' flexibility. The ear-shoulder, chin-sternum (proximal end) and chin-wall distances of the patients will be measured with a tape measure. | Pre-treatment assessment. |
| Flexibility Assessment | A tape measure will be used to assess patients' flexibility. The ear-shoulder, chin-sternum (proximal end) and chin-wall distances of the patients will be measured with a tape measure. | Second evaluation immediately after the end of 4 weeks of treatment. |
| Flexibility Assessment | A tape measure will be used to assess patients' flexibility. The ear-shoulder, chin-sternum (proximal end) and chin-wall distances of the patients will be measured with a tape measure. | Control evaluation 1 month after the end of treatment (third evaluation). |
| Measure | Description | Time Frame |
|---|---|---|
| Functional Status Assessment Questionnaire | Neck Disability Index (NDI) will be used to evaluate the functional status of patients. The NDI consists of 10 titles: pain severity, self-care, lifting, reading, headache, concentration, working, driving, sleeping and recreation. Individuals included in the study are asked to give points between 0 (no disability) and 5 (complete disability) to each title. The total score ranges from 0 (no disability) to 50 (complete disability). |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Muhammed Ãœsame TAÅž, Lecturer | Inonu University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Inonu University | Malatya | 44280 | Turkey (Türkiye) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| IASTM Technique Application | Other | Instrument-assisted soft tissue mobilization application 2 sessions per week together with 3 sessions of classical physiotherapy per week for 4 weeks. IASTM application; A total of 4 minutes will be applied to the sternocleidomastoideus, levator scapula, scalene muscles and upper part of the trapezius for a total of 4 minutes (2 minutes to the right, 2 minutes to the left region). |
|
| Foam Roller Technique Application | Other | 2 sessions of foam roller technique per week along with 3 sessions of classical physiotherapy per week for 4 weeks. Foam roller application; A total of 4 minutes will be applied to the sternocleidomastoideus, levator scapula, scalene muscles and upper part of the trapezius for a total of 4 minutes (2 minutes to the right, 2 minutes to the left region). |
|
| Pain Assessment |
Visual Analog Scale (VAS) will be used to evaluate the pain of individuals. |
| Pre-treatment assessment. |
| Pain Assessment | Visual Analog Scale (VAS) will be used to evaluate the pain of individuals. | Second evaluation immediately after the end of 4 weeks of treatment. |
| Pain Assessment | Visual Analog Scale (VAS) will be used to evaluate the pain of individuals. | Control evaluation 1 month after the end of treatment (third evaluation). |
| Pre-treatment assessment. |
| Functional Status Assessment Questionnaire | Neck Disability Index (NDI) will be used to evaluate the functional status of patients. The NDI consists of 10 titles: pain severity, self-care, lifting, reading, headache, concentration, working, driving, sleeping and recreation. Individuals included in the study are asked to give points between 0 (no disability) and 5 (complete disability) to each title. The total score ranges from 0 (no disability) to 50 (complete disability). | Second evaluation immediately after the end of 4 weeks of treatment. |
| Functional Status Assessment Questionnaire | Neck Disability Index (NDI) will be used to evaluate the functional status of patients. The NDI consists of 10 titles: pain severity, self-care, lifting, reading, headache, concentration, working, driving, sleeping and recreation. Individuals included in the study are asked to give points between 0 (no disability) and 5 (complete disability) to each title. The total score ranges from 0 (no disability) to 50 (complete disability). | Control evaluation 1 month after the end of treatment (third evaluation). |
| Joint Range of Motion Assessment | A goniometer will be used to evaluate the patients' range of motion. | Pre-treatment assessment. |
| Joint Range of Motion Assessment | A goniometer will be used to evaluate the patients' range of motion. | Second evaluation immediately after the end of 4 weeks of treatment. |
| Joint Range of Motion Assessment | A goniometer will be used to evaluate the patients' range of motion. | Control evaluation 1 month after the end of treatment (third evaluation). |
| Quality of Life Assessment Questionnaire | The Nottingham Health Profile (NHP) will be used to assess patients' quality of life. The Nottingham health profile is a scale used to assess patients' levels of emotional, social and physical activity. The questions are divided into 6 subgroups as energy level (3 questions), pain (8 questions), emotional reaction (9 questions), sleep (5 questions), social isolation (5 questions) and physical activity limitation (8 questions). A total of 38 questions in 6 groups have separate point values, and each item is answered "yes" or "no". A scoring system has been established so that each subgroup will have a total of 100 points. | Pre-treatment assessment. |
| Quality of Life Assessment Questionnaire | The Nottingham Health Profile (NHP) will be used to assess patients' quality of life. The Nottingham health profile is a scale used to assess patients' levels of emotional, social and physical activity. The questions are divided into 6 subgroups as energy level (3 questions), pain (8 questions), emotional reaction (9 questions), sleep (5 questions), social isolation (5 questions) and physical activity limitation (8 questions). A total of 38 questions in 6 groups have separate point values, and each item is answered "yes" or "no". A scoring system has been established so that each subgroup will have a total of 100 points. | Second evaluation immediately after the end of 4 weeks of treatment. |
| Quality of Life Assessment Questionnaire | The Nottingham Health Profile (NHP) will be used to assess patients' quality of life. The Nottingham health profile is a scale used to assess patients' levels of emotional, social and physical activity. The questions are divided into 6 subgroups as energy level (3 questions), pain (8 questions), emotional reaction (9 questions), sleep (5 questions), social isolation (5 questions) and physical activity limitation (8 questions). A total of 38 questions in 6 groups have separate point values, and each item is answered "yes" or "no". A scoring system has been established so that each subgroup will have a total of 100 points. | Control evaluation 1 month after the end of treatment (third evaluation). |